These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31212967)

  • 1. Integrative Analysis of Genomic and Clinical Data Reveals Intrinsic Characteristics of Bladder Urothelial Carcinoma Progression.
    Zhou B; Guo R
    Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31212967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiles of variation integration genes in bladder urothelial carcinoma.
    Wang JM; Wang YQ; Gao ZL; Wu JT; Shi BK; Yu CC
    Genet Mol Res; 2014 Apr; 13(2):3486-94. PubMed ID: 24841793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting progression of bladder urothelial carcinoma using microRNA expression.
    Rosenberg E; Baniel J; Spector Y; Faerman A; Meiri E; Aharonov R; Margel D; Goren Y; Nativ O
    BJU Int; 2013 Nov; 112(7):1027-34. PubMed ID: 23387295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
    Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
    Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
    Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
    Guo CC; Dadhania V; Zhang L; Majewski T; Bondaruk J; Sykulski M; Wronowska W; Gambin A; Wang Y; Zhang S; Fuentes-Mattei E; Kamat AM; Dinney C; Siefker-Radtke A; Choi W; Baggerly KA; McConkey D; Weinstein JN; Czerniak B
    Eur Urol; 2016 Oct; 70(4):611-620. PubMed ID: 26988609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.
    Huang T; Yang J; Cai YD
    Biomed Res Int; 2015; 2015():358125. PubMed ID: 25802847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.
    Sanford T; Meng MV; Railkar R; Agarwal PK; Porten SP
    Clin Epigenetics; 2018; 10():19. PubMed ID: 29456764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weighted gene co-expression network analysis can sort cancer-associated fibroblast-specific markers promoting bladder cancer progression.
    Liu B; Zhan Y; Chen X; Hu X; Wu B; Pan S
    J Cell Physiol; 2021 Feb; 236(2):1321-1331. PubMed ID: 32657439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data.
    de Matos Simoes R; Dalleau S; Williamson KE; Emmert-Streib F
    BMC Syst Biol; 2015 May; 9():21. PubMed ID: 25971253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic analysis on DNA methylation and the expression of both mRNA and microRNA in bladder cancer.
    Zhu J; Jiang Z; Gao F; Hu X; Zhou L; Chen J; Luo H; Sun J; Wu S; Han Y; Yin G; Chen M; Han Z; Li X; Huang Y; Zhang W; Zhou F; Chen T; Fa P; Wang Y; Sun L; Leng H; Sun F; Liu Y; Ye M; Yang H; Cai Z; Gui Y; Zhang X
    PLoS One; 2011; 6(11):e28223. PubMed ID: 22140553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct microRNA alterations characterize high- and low-grade bladder cancer.
    Catto JW; Miah S; Owen HC; Bryant H; Myers K; Dudziec E; Larré S; Milo M; Rehman I; Rosario DJ; Di Martino E; Knowles MA; Meuth M; Harris AL; Hamdy FC
    Cancer Res; 2009 Nov; 69(21):8472-81. PubMed ID: 19843843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental genes significantly afflicted by aberrant promoter methylation and somatic mutation predict overall survival of late-stage colorectal cancer.
    An N; Yang X; Cheng S; Wang G; Zhang K
    Sci Rep; 2015 Dec; 5():18616. PubMed ID: 26691761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and molecular markers of urothelial premalignancy and malignancy.
    Cordon-Cardo C; Cote RJ; Sauter G
    Scand J Urol Nephrol Suppl; 2000; (205):82-93. PubMed ID: 11144907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
    Qiu JG; Shi DY; Liu X; Zheng XX; Wang L; Li Q
    J Cell Physiol; 2019 May; 234(5):6976-6982. PubMed ID: 30317582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression pattern of p53-binding protein 1 as a new molecular indicator of genomic instability in bladder urothelial carcinoma.
    Matsuda K; Kawasaki T; Akazawa Y; Hasegawa Y; Kondo H; Suzuki K; Iseki M; Nakashima M
    Sci Rep; 2018 Oct; 8(1):15477. PubMed ID: 30341375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene discovery in bladder cancer progression using cDNA microarrays.
    Sanchez-Carbayo M; Socci ND; Lozano JJ; Li W; Charytonowicz E; Belbin TJ; Prystowsky MB; Ortiz AR; Childs G; Cordon-Cardo C
    Am J Pathol; 2003 Aug; 163(2):505-16. PubMed ID: 12875971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
    von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
    J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer.
    Song BN; Kim SK; Chu IS
    Exp Mol Med; 2017 Jan; 49(1):e282. PubMed ID: 28082741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.